Extracorporeal Blood Treatment Profile Management Interface
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current extracorporeal blood treatment systems lack efficient user interfaces for selecting, modifying, and creating treatment profiles, leading to complexity and potential errors in configuring treatment settings for patients.
Innovation Solution
The development of a system with a graphical user interface that allows users to select, create, and modify treatment profiles, including presets for therapy types, therapy sets, anticoagulation types, flow rates, and alarm limits, using a touchscreen or similar input apparatus, enabling configuration and storage of profiles for future use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If multiple treatment settings and parameters are manually configured by a clinician, then comprehensive treatment customization is achieved, but the setup time and complexity increase significantly
Solution Approach 1:
The system stores multiple pre-configured treatment profiles that contain predefined settings for various parameters including therapy type, anticoagulation type, and therapy set configurations. Clinicians can select from these pre-prepared profiles rather than manually configuring each parameter from scratch, significantly reducing setup time while maintaining treatment customization through profile selection and modification.
Solution Approach 2:
The system allows clinicians to copy existing treatment profiles and modify them for new treatments. This copying mechanism enables rapid reproduction of proven treatment configurations while allowing necessary adjustments for individual patient needs, balancing standardization efficiency with customization requirements.
2Adaptability or versatility
If numerous treatment parameters are configured manually, then complete treatment configuration is achieved, but the risk of errors increases
Solution Approach 1:
Treatment profiles are pre-configured with appropriate parameter values and relationships established beforehand. When a profile is selected, the system automatically applies these pre-validated settings, reducing the opportunity for clinicians to make configuration errors during the setup process while maintaining complete treatment configuration.
Solution Approach 2:
The graphical user interface provides visual feedback to clinicians during profile selection and modification, displaying the current state of treatment parameters and confirming selections. This feedback mechanism helps clinicians verify that the correct profile is selected and that modifications are appropriate, reducing configuration errors.
3Adaptability or versatility
If a comprehensive profile management system is implemented, then profile creation and modification capabilities are enhanced, but the device complexity increases
Solution Approach 1:
The graphical user interface serves as an intermediary between the clinician and the complex profile management system. It provides a simplified, intuitive interface for selecting, creating, and modifying treatment profiles, hiding the underlying system complexity from the user while enabling comprehensive profile management capabilities.
Solution Approach 2:
The system implements a universal profile management framework that handles multiple treatment types, parameters, and configuration options through a single integrated interface. This multi-functional approach allows the system to manage diverse treatment profiles (different therapy types, anticoagulation types, therapy sets) without requiring separate complex systems for each, reducing overall device complexity.
Data Source
AI summary
Extracorporeal blood treatment systems and methods to use and modify/create treatment profiles for extracorporeal blood treatments. For example, treatment profiles may include one or more preset, or predefined, settings or values for an extracorporeal blood treatment such as, e.g., therapy type, therapy set (e.g., tubing set, filter set, etc.), anticoagulation type, and one or more flow rates, etc.


